CHASE is delighted to welcome Caroline Pond as NHS Partnership Working Director.
Caroline brings deep practical clinical experience following her role as Operations Director at Medacy, a CHASE company that delivers pharmacist-led clinical services across the UK. Caroline has worked as a pharmacist across general practice, secondary care and the pharmaceutical industry for over thirty years, building deep understanding of patient needs, medicines and practical delivery in clinical settings.
In this new role, Caroline will oversee clinical programme design, with a highly practical and sustainable approach to CHASE’s Partnership Working programmes to meet the mutual needs of patients, healthcare professionals, the NHS, and Industry.
Upon the appointment, Emma Busby, Chief Operations Officer, said:
“Caroline is a fantastic addition to our Partnership Working team as we see increasing demand from our clients for sustainable Partnership Working programmes. Her deep experience of delivering successful clinical programmes and extensive relationships across the NHS are a real boost for CHASE, and just one of the many successes from our acquisition of Medacy.”
Explore our latest thinking, event updates and industry insights to stay informed.
Kent and Medway has signed the first local variation of the PCN DES, worth £10 million a year. CHASE assesses what the framework still leaves unsettled.
From April 2027, NHS Carbon Reduction Plan rules demand full scope 3 emissions data. CHASE assesses what this means for pharma and medtech suppliers.
Yvette Cooper is the UK's new health secretary after a reshuffle that also reshaped the medtech brief. Here's what it means for pharma, medtech and NHS teams.
.svg)
